Human ASX: AHI AdvancedHumanImaging.

25
1 Health Risks Health Indicators Circumference Composition Blood Diagnostics Vital Signs JUNE 2021 ASX: AHI Advanced Human Imaging. Advanced Human Imaging. Fitness + mHealth + Apparel + Life & Health Insurance + Musculoskeletal Assessment Skin Conditions

Transcript of Human ASX: AHI AdvancedHumanImaging.

1

Health Risks Health Indicators

Circumference

Composition

BloodDiagnostics

Vital Signs

JUNE 2021

ASX: AHI

AdvancedHumanImaging.

Advanced Human Imaging.

Fitness+ mHealth+ Apparel+Life & Health Insurance+

MusculoskeletalAssessment

Skin Conditions

22

62%

Top 20Shareholders

74%

Top 50Shareholders

49%

Top 10Shareholders

45%

Staff, Board, AdvisorsShareholders

Corporate Overview.

All values as at 10/03/2021

Ticker ASX:AHI

Share Price (AUD) $1.915

Current Shares On Issue (undiluted) 131.33m

Capitalisation $251.49m

Convertible Note $1.95m

Enterprise Valuation $248.56m

Cash at Bank $4.9m

Aug 2020 – Mar 2021

Approx. Monthly Burn (operating activities)

– Average Burn During Previous Quarter (December ’20 QTR) $282K

– Average Burn YTD $192K

Performance Rights and Options

– Options 10.33m

– Performance Rights 22.15m

Fully Diluted Shares 163.80m

0

0.5

1

1.5

2

2.5

2020

-08-18

2020

-08-28

2020

-09-07

2020

-09-17

2020

-09-27

2020

-10-07

2020

-10-17

2020

-10-27

2020

-11-06

2020

-11-16

2020

-11-26

2020

-12-06

2020

-12-16

2020

-12-26

2021

-01-05

2021

-01-15

2021

-01-25

2021

-02-04

2021

-02-14

2021

-02-24

2021

-03-06

Capital Structure Share Price Performance (AUD)

Share Holder Breakdown

33

CompleteScan: Edge AI Technology.Smartphone based human scanning technology, unlocking a diverse range of data-driven applications.

Fitness+ mHealth+ Life & Health Insurance+ Apparel+

Platforms Issued Patents

SOLUTION

FaceScanUnlock vital signs,health indicators,

health risks.

MKScanAI-Powered

MusculoskeletalOptimization Platform.

POTENTIAL ACQUISITION

HemaScanBlood biomarker assisted

chronic diseaseassessment & monitoring.

COMING SOON

+

DermaScanSkin disease detection

for over 500 skinconditions.

COMING SOON

BodyScanBody circumference,

body composition, healthindicators, health risks.

44

BodyScan.A pioneering body scan technology by AHI. It combines proprietary deep learning models and state of the art imageprocessing techniques that return body circumference, body composition, multiple health risks, and indicators.

ACCURACY AND REPEATABILITY 2

+ Hardware accelerated, proprietarycode runs on the device, delivering anear realtime capture process

+ Machine Learning models aresynchronized remotely to reduce appsize

+ Human joint mapping ensuresaccuracy and repeatability

Chest Waist Hips

Thighs + 3D Model

Working with partners’specialized needs to

extend our data offering.

Body Fat %

Waist-Hip Ratio

Waist-Height Ratio

Waist Circumference

Obesity Central Obesity

Type-2 Diabetes

Metabolic Syndrome 1 ...

Auto-Size Auto-Fit

Custom-Fit

APPAREL

Inseam

Virtual Try-on

Biceps Calves Shoulders

3D Enhancements

FITNESS

...

Weight Inference

Guide andSetup

ResultsFront and SidePicture

1 Metabolic Syndrome is available by combining a Face Scan and BodyScan data, or supplying Blood Pressure.2 Both accuracy and repeatability have been validated by Professor Timothy Ackland, Professor of Applied.Anatomy and Biomechanics, The University of Western Australia – ASX Announcement 18/10/2018.3D Artwork by Aleksandrs K

WAIST

CHEST

HIPSBody Fat %

COMPLETESCAN

98%HIPS

97%WAIST

98%CHEST

97%THIGHS

98%REPEATABILITY

PLATFORMS BODYSCANIN UNDER

60s

1 2

THIGHS

+ Compared to ISAK standard baselinemeasurements.

High Performance Circumference

How it Works

Composition

Risk Indicators

Health Risks

Validation

Specialized Data

Fitness+ mHealth+ Life & Health Insurance+ Apparel+

Phoneplaced at

hips height

TypicalScanSetup

Evenly litroom

Unclutteredbackground

55

66

2

FaceScan.Transdermal Optical Imaging techniques pave the way to a non-intrusive and easy-to-use method formeasuring vital signs, and risks associated with Chronic Disease.

+ Advanced facial tracking locks ontokey regions of interest

+ Transdermal Optical Imaging (TOI) isused to extract facial blood flowinformation from beneath the skin

+ Advanced signal processing anddeep learning models measure vitalsigns and predict physiological andpsychological effects

Blood Pressure Heart Rate

Respiratory Rate

Stress

Cardiac WorkloadHeart Rate Variability

Irregular Heart Beats

Cardiovascular Disease

Heart Attack

Stroke

Metabolic Syndrome 2

Face Scan

TransdermalOptical

Imaging (TOI)95%

BLOOD PRESSUREDIASTOLIC

95%BLOOD PRESSURE

SYSTOLIC

95%PULSE

PRESSURE

99%REPEATABILITY

99%HEART RATE

Accuracy & Validation 1

1 Reference Device: Biopac Systems, ECG, 3-leads. Biopac respiration module with pneumatic belt. Biopac with continuous BPmodule, and Nurse using Auscultation Method. Framingham Study for risk prediction.2 Metabolic Syndrome is available by combining a Face Scan and BodyScan data, or supplying Blood Pressure.3D Artwork by Hossam Ahmed

Results

1

Guide/Setup

Platforms

Vital Signs, Unlocked Vital Signs

Health Risks

Health Indicators

How It Works

COMPLETESCAN

30sSCAN

DURATION

Fitness+ mHealth+ Life & Health Insurance+

77

DermaScan.The intelligent, instant dermatological scanner with superhuman diagnostic capabilities, capableof screening for over 500 skin conditions.

COMPLETESCAN

Deployment

EvaluationTraining

User UsageData Review

Database Curation

+ Self-training AI that improves with every scan.

+ DermaScan can detect 588 skin conditions in133 categories, from the common to thecomplex.

+ Save time and increase patient throughput.

+ Instant second opinion leads to betteroutcomes.

+ Reduce malpractice risk.

+ Attach a dermatoscope for enhanced accuracy.

+ Over 160,000 users. Used over 500,000 times,with 12% of the userbase being clinicians.

1

Acne vulgaris Contact dermatitis

Non-scarring alopecia

Cellulitis Common warts

Insect bites Paronychia

Lichen planus Psoriasis

Cicatricial alopecia

Tinea corporis

Melanocytic nevus

Atopic eczema

Scabies Tinea pedis

Basal cell carcinoma

Impetigo

Ulcers

Shingles

Vitiligo

+568 more

73%SENSITIVITY

54%PRECISION

87%ACCURACY

95%SPECIFICITY

2

Location andQuestions

Results

1

Photo

1.“Triage vs. USA Board-Certified Physicians”, Company Overview September 2020

2.MyFiziq Signs Binding Term Sheet with Triage Technologies to Integrate the Triage Technology into the CompleteScan SaaS Offering.Refer to ASX announcement 3/12/2020.

Instant. Accurate. Affordable.

Clinical Validation

Common Conditions

How It Works

Fitness+ mHealth+ Life & Health Insurance+

Platforms Standards

88

MKScan.Empowering athletes to independently perform functional movement assessments; Instantly obtainingobjective feedback with: Mobility, Stability, Strength, and Movement Control scores.

+ Time Saving – Instant set-up, 8-minute pro assessment andreal-time feedback. Saveprecious time for staff andathletes alike.

+ Objective Measurements -Automated screening processensures consistent scores,eliminating the need for anyexpertise or prior knowledge.

+ Comprehensive Coverage -Offers the widest range ofautomated evidence-basedfunctional movement tests.

+ Comparative Scores - Athletescores are calculated in relationto same level norms,maximizing the accuracy levelof the results.

+ Portability - Perform automatedmovement assessmentsanytime, anywhere.

+ Large-Scale Assessments -proven to assess hundreds ofsubjects in just a few hours, theultimate solution for colleges,youth academies and tacticalforces.

Validated by world-leading academic institutions.

Highlights

Validation

The University ofNorth Carolina

The Universityof Connecticut

Military Academyat West Point

POTENTIAL ACQUISITIONCOMPLETESCAN

Fitness+ mHealth+ Life & Health Insurance+

99

HemaScan.The low-cost and accessible point of care blood diagnostics and monitoring solution.

PRODUCT

+

+ The patented Aina device provides rapid,accurate readouts of key blood chemistryelements in several chronic diseasecategories: Cardiovascular, Renal, andMetabolic (CVRM).

+ Low-cost, point-of-care (POC) blooddiagnostics that is accessible and affordable.

+ Real-time, lab-quality results within minutes.

+ Simple to Use.

+ Seamless Connectivity.

The Aina tests include:

+ Diabetes - HbA1c and glucose.

+ Heart disease: Total cholesterol,triglycerides, total HDLcholesterol, NT-pro-BNP, andPotassium.

+ Kidney disease: SerumCreatinine and hemoglobin.

Highlights Aina Device

Clinical Validation

Compliance

Fitness+ mHealth+ Life/Health Insurance+

COMING SOON

HbA1c Glucose Hemoglobin

97.6% sampleswithin 10% bias

96.5% sampleswithin 15% bias

94.4% sampleswithin 10% bias

Total Cholesterol HDL Cholesterol Triglycerides

100% sampleswithin 15% bias

100% sampleswithin 15 mg/dL bias

97.6% sampleswithin 15% bias

COMPLETESCAN

1010

Doctors, NursesTrip to Doctor,Specialist

Pathology ECG Machine

Tape measure,calipers

Blood PressureMonitor

Respiration BeltSensor

DEXA Scanner Dermatologist MusculoskeletalPhysician

ISAK AccreditedProfessional

Body compsositionscanner, scales

vv

Accessible Healthcare through earlyintervention with actionable data.

AHI CompleteScan.

FaceScan MKScan HemaScan

+

DermaScanBodyScan

1111

Unlock significant aspects of an individual's health, fitness & wellbeing via the convergence ofon-device scanning and external data.

Unlocking Data Through Convergence.

Partner Data

Family History

Questionnaires

Analytics

Product Data ...

Health Profile

BODYSCAN

FACE SCAN

DERMASCAN

MKSCAN

HEMASCAN

Wearables

Connected Health

Telemedicine

Connected Fitness

Circumference

Composition

Health Risks

Vital Signs

Musculoskeletal Wellness

...

Health Indicators

Blood Diagnostics

AHI Data

PLATFORM

1212

The Path To Go-Live.Whilst the destination is important, having a smooth path to get there is paramount. Here’s what to expect.

Go-Live subjectto partner'sdiscretion.

RECENT TRANSACTIONS

$2.1B 2$345M 3$8B 5 $500M 4 1313

+ A true biometric profile provides partners with a snapshotof someone's health

+ Remote coaches benefit from digital health profiles forcustom fitness programs rather than a one size fits allapproach

+ Utilize vital signs after workouts to gauge the physicalintensity

+ Programs are dynamically selected based on a member'sbiometric health status

+ Track dimensional change over time and the effectivenessof programs

+ Gamify dimensional change as the health of membersimprove

1. by 2023 “Physical Activity Is an $828Billion Market – To Reach $1.1 Trillion+ by2023” Global Wellness Instittute, 2019.

2. “Google buys Fitbit for $2.1 billion”, TheVerge, Nov 1 2019

3. “Under Armour to sell MyFitnessPal for$345 million, after acquiring it in 2015 for$475 million” Techcrunch, Oct 30, 2020

4. “Lululemon set to acquire home fitnessstartup Mirror for $500M” Techcrunch, June30, 2020

5. “Peloton prices IPO on high end ofexpectations, valuing digital fitness companyat $8.1 billion” CNBC 16 Sep, 2020

Clients andPartners.

�100,000

�100,000

�250,000�400,000

�410,000

�500,000 �TBC

�TBC

Partner User Target�

Fitness.

$1.1T 1

Measure your changes, track your progress,and see the transformation.

VERTICAL

Market Size

Highlights

d eReal-time WorkoutMonitoring.During workout stages, thepulse is measured usingthe face scan. Both thecoach and member can seethe results, ensuring thetarget activity level ismaintained.

Program Summary.Once the program iscompleted, the summaryscreen shows where themost change occurred on the3D model.

c eCoach Interaction.The coach can view thechanges so far during theprogram, makingcorrections wherenecessary.

1414

Integration Example: Fitness.In App and On-device Fitness Results Tracking.

ba eCoach Interaction.An in-app guide ensures arecent face and body scanis completed before thecoach can prepare theprogram for the member'sunique health profile.

Unique FitnessJourney.A new member signs up fora fitness app. As part of theonboarding, the membersets fitness goals and takesa body and face scan. Arecommended program isdisplayed based on theirgoals and scan results.

All app screens are examples of an integration.

BODYSCAN FACE SCAN

VERTICAL

Partner User Target�

1515

+ Removes misclassification of health risk from old-fashionedBMI-dependent systems

+ Upfront assessment and early intervention leads to lowerclaim payouts due to better health outcomes

+ Limits the need to use expensive and inaccessible medicalscanners and blood pressure, monitors

+ Estimated premiums underwritten by AI support systems:$20 billion by 2024, up from an estimated $1.3 billion in 2019

Highlights.

1.by 2020, “Global Life & Health InsuranceCarriers Industry - Market Research Report”,IBISWORLD, Aug 18 2020,

2.“Report: Digital Health VC Funding Surgesto Record $4.9 Billion in 2018”, HealthcareInnovation, July 18 2018

3.“23andMe lands $300 million investmentfrom GlaxoSmithKline”, Forbes, 2018

4.“Teladoc to take over Livongo in $18.5Bdigital health deal”, Fierce Biotech, Aug 52020

5.“Siemens Healthineers moves deeper intocancer care, picking up radiotherapydeveloper Varian Medical for $16.4B”, FierceBiotech, Aug 3 2020

6.“HeartFlow Completes Series E Financing,Securing $240 Million”, Business Wire, 14Feb 2018

7.“AI-Underwritten Insurance Premiums toGo From $1.3B to $20B Globally by 2024”Juniper” Aug, 2019

$291M 2$300M 3 $240M 6$16.5B 5$18.5B 4

Market size.

$4.4T 1

RECENT TRANSACTIONS

Understanding the consumer through digitalaccess to primary biomarkers of chronic diseaseand body composition allows predictive healthoutcomes and dynamic risk-adjusting policyunderwriting.

Life/HealthInsurance.

�100,000

�1,000,000

�100,000

�TBC

�100,000�TBC

�500,000

RESELLER

Clients,Partners.

VERTICAL

1616

Integration Example: Life/Health Insurance.Dynamic Underwriting, Chronic Disease Intervention, and Prevention.

aSelf-ReportedApplicationA recent Face and BodyScanis submitted by a potentialpolicyholder, along with self-reported information, suchas height and weight.

Health AssessmentFace and BodyScantechnology is available topolicyholders, allowing at-home assessment ofchronic diseases.

Results to ActionThe results are sent to theprovider and shown to thepolicyholder, showing themwhat course of action totake next.

The provider intervenes andprovides extra support toimprove health and reducerisk.

Road to PreventionA regular Face andBodyScan are conductedwhile on a health journey,showing improvementtrends and validatingproviders' offerings.

b c a Self-reported weightshows nominal health.

Weight inference is used tocalculate alternate results,along with Health Risks.

b

c

c

All app screens are examples of an integration.

BODYSCAN FACE SCAN

EXAMPLE 1 EXAMPLE 2

VERTICAL

1717

�1,000,000

�100,000

�100,000

�100,000

�TBC

�100,000

�TBC

�500,000

�250,000

RESELLER

�TBC

Clients,Partners.

$16M 3$18.5B 2 $10M 4 $38M 5$600M 6

RECENT TRANSACTIONS

mHealth.

$1.4T 1, A

Highlights.

Market size.

+ Telemedicine is at the forefront of innovation, with AHIredefining how the smartphone is used for remotemedical consultation

+ CompleteScan, a dual-scan offering, provides acomprehensive data-set to predict the early onset ofchronic diseases

+ Preventative wellness and health monitoring plans canbe enacted, ensuring a healthy life for all, no mattertheir location

+ AHI helps employers protect and engage theiremployees, resulting in improved employee retention,less sick leave, and increased ROI

Digital technologies are becoming an essentialresource for remote medicine and personalizedcare for individuals and groups.

1.in 2018, Sectors: TeleHealth, WorkplaceWellness, Preventive & PersonalizedMedicine and Public Health, Healthy Eating,Nutrition & Weight Loss, "Move to be Well:The Global Economy of Physical Activity",PDF pg. X, Global Wellness Institute, 2019A in 2019, "Telehealth Market Size, Share &COVID-19 Impact Analysis, By Type...",Fortune Business Insights, Jul 2020

2.“Teladoc to take over Livongo in $18.5Bdigital health deal”, Fierce BioTech, Aug 52020

3.“OptimizeRx acquires RMDY Health for$16M to expand digital messaging platform”,Fierce Healthcare, Sept 6 2019

4.“Austin-Based Remedy Raises $10M ForTelemedicine Platform And House Calls”,Crunchbase News, June 26,2019

5.“Buoy Health nabs $38M Series C financingfrom Cigna, Optum, and Humana”, FierceHealthcare, Nov 11 2020

6.“Teladoc to acquire InTouch Health for$600M”, Medcity News”, Jan 12 2020

Partner User Target�

VERTICAL

1818

BODYSCAN FACE SCAN

Integration Example: mHealth.Remote Assessment and Health Monitoring.

a b c d aBooking AppointmentRemote appointmentbooked with a remotemedical professional.

Sharing ResultsOnce scans are complete,the results are sharedwith the medicalprofessional.

Video AppointmentDuring the call, the scanresults are displayed anddiscussed by the medicalprofessional.

Professional AdviceFeedback from the healthprofessional containslifestyle, diet and nutrition,exercise, and sleepadjustments in order toimprove health conditions.

Built-in MonitoringDoctor-patient monitoringallows for progress to betracked remotely.

Patients provide extendedfeedback with each weeklyscan assessment.

All app screens are examples of an integration.

EXAMPLE 1 EXAMPLE 2

VERTICAL

$50-70M 2 $UN 4$2.1B 7 $1.1B 5 $15.8B 6

RECENT TRANSACTIONS

1919

+ Reduce wrong-size returns and related costs

+ Auto-size and fit matching algorithms

+ Reduced time to purchase

+ Custom Apparel

+ Increases retention and customer loyalty throughbetter engagement and purchase personalization

1. by 2023, “Apparel Global Market Report 2020-30: Covid 19 Impact andRecovery”, Research & Markets, April 2020

2. “Amazon spent at least $50 million to buy 3D body scanning start-up BodyLabs, report says”, CNBC, 3 Oct 2017

3. “Nike Acquires Invertex”, Nike News, 9 Apr 2018

4. “Mega Partnership: Farfetch Links With Alibaba, Richemont” WWD, Nov 52020

5. “LVMH agrees $15.8bn takeover of Tiffany”, The Guardian, 29 Oct 2020

6. “Supreme Streetwear Brand Sold to VF in $2.1 Billion Deal” WSJ Nov 9,2020c

Example brands targeted by AHI.

Highlights.

Market size.

$810B 1

BY 2023

Apparel.AHI provides the ability to measure a personaccurately. Not only for online purchasing ofclothing but also in-store purchasing,providing a satisfying shopping experience.

PotentialApparel

Partners.

Potential Apparel Partners.

VERTICAL

2020

ca b Custom ApparelCustom art, initials, andbranding graphics can beplaced by an individualshopper, creating trulycustom clothing.

Custom ApparelFinal custom apparelpurchase with allpersonalization intact,ready for expresscheckout.

a bQR CodesSize and fit options areauto-matched by brand,driving online and in-storeshopping experiences.

Auto-Size and Auto-FitA product's size and fit areauto-populated based onthe most recent BodyScan.

Scan-based ResultsBody scan measurementsare used to browse theshop, excluding items thatare the correct size.

Integration Example: Apparel.Auto-Sizing and Auto-Fit.

EXAMPLE 1 EXAMPLE 2

All app screens are examples of an integration.

BODYSCAN

VERTICAL

2121

�TargetUsers

�1,000,000From US$2.99 user/mo

�100,000From US$2.15 user/mo

�410,000From US$1.50 user/mo

�400,000From US$2.00 user/mo

�600,000From US$1.30 user/mo

�1,000,000From £3.49 user/mo

�1,000,000

�TBCFrom $TBC user/mo

From $3.57 user/mo

�100,000From US$3.49 user/mo

�100,000From US$2.99 user/mo

�500,000From US$1.50 user/mo

�250,000From US$3.49 user/mo

�200,000From $TBC user/mo

�250,000From US$1.50 user/mo

RESELLERS BCT PARTNERS TECHNOLOGY PARTNERS

CurrentCommercial

Network.16 Partnerships

6,010,000 Target Users3 Technology Partners

2 Resellers

2222

Vlado BosanacChairman & CEO

+ Over 25 years experience in venture capital and privateequity.

+ Entrepreneur, advisor and strategy consultant.

+ Successfully funded 10+ start-ups.

+ Extensive public company experience.

+ Highly experienced in transaction origination.

Mike MelbyNon-Executive Director

+ Fitness industry executive.

+ Tech company founder (PayDivvy - acquired byHigher One, TapIt – acquired by VC-backedPhunware).

+ Investment banker and private equity investor.

+ MBA Entrp. Man, BA, Political Economy.

+ 15+ years experience in the ICT industry.

+ Director of a number of private companies in Australiaand Asia.

+ Former founder of Canberra Data Centres which wereacquired by Infratil and Commonwealth SuperannuationCorporation for an enterprise value of $1.16 billion in2016.

+ Shareholder and Executive Director of anSingapore Exchange listed company.

+ Over 20 years in accounting and corporatefinance.

+ Entrepreneur, advisor and investor.

+ Fellow of ACCA (UK) and MIA (Malaysia).

AHI Board of Directors.

Dato Low Koon PohNon-Executive Director

Nick ProsserNon-Executive Director

TEAM

2323

Management Team.

+ Venture capital and private equity investor, start-upfounder, and brand executive.

+ Former GM at Nike+ Fuel Lab and Global Head of BusinessDevelopment for Nike+.

+ MBA, BA Economics and Japanese.

+ Currently Chief Product Officer at Pvolve – FitTech startup based inNYC.

+ Recently Chief Digital Officer at Beachbody, LLC - launched Beachbodyon Demand leading to US$1 Billion in total annual revenue.

+ Previously SVP, Digital Media Fox Broadcasting (Fox.com), VP,Product Management – Yahoo! , AOL Executive Director, ProductManagement.

+ Former U.S. Army Officer.

Brian KirkbrideStrategic Advisor

Bill BradfordChief Business Officer, USA

David TabbChief Operations Officer

Terence StuppleChief Technology Officer

Dr Amar El-SallamChief Science Officer

Ryan SnowdenChief Design Officer

Phillip CooperLead Software Developer

Adam PhoenixLead Software Developer

Dr. Neeraj DhungelCV and ML Scientist

Steven RichardsCFO, Company Secretary

+ Qualified Chartered Accountant 15+ years experience atCFO level.

+ Worked in high-growth and tech environments at PUMASports, Quicksilver, HealthEngine, Airscope industries, andRameSys Global.

+ (Hons) B.Comm, MBA, Chartered Accountant, Finance,Leadership and Strategy.

Supported by

TEAM

24

This presentation (“Presentation”) has been prepared by Advanced Human Imaging Pty Ltd (“Advanced HumanImaging” or “Company”).

You must read and accept the conditions in this notice before considering the information set out in or referred to inthis Presentation. If you do not agree, accept or understand the terms on which this Presentation is supplied, or ifyou are subject to the laws of any jurisdiction in which it would be unlawful to receive this Presentation or whichrequires compliance with obligations that have not been complied with in respect of it, you must immediately returnor destroy this Presentation and any other confidential information supplied to you by Advanced Human Imaging. Byaccepting this document, you acknowledge and agree to the conditions in this notice and agree that you irrevocablyrelease Advanced Human Imaging from any claims you may have (presently or in the future) in connection with theprovision or content of this Presentation.

NO OFFER

This Presentation is not a prospectus, product disclosure statement or other offering document underAustralian law (and will not be lodged with ASIC) or any other law. This Presentation is for informationpurposes only and is not an invitation or offer of securities for subscription, purchase or sale in any jurisdiction(and will not be lodged with the ASIC).

This Presentation does not constitute investment or financial product advice (nor tax, accounting or legal advice) orany recommendation to acquire shares of Advanced Human Imaging and does not and will not form any part of anycontract for the acquisition of shares of Advanced Human Imaging.

SUMMARY INFORMATION

This Presentation contains summary information about Advanced Human Imaging, its subsidiaries and theiractivities which is current as at the date of this Presentation. The information in this Presentation is of a generalnature and does not purport to be complete nor does it contain all the information which a prospective investormay require in evaluating a possible investment in Advanced Human Imaging or that would be required in aprospectus or product disclosure statement prepared in accordance with the requirements of the Corporations Act.While Advanced Human Imaging has taken every effort to ensure the accuracy of the material in the presentation,neither the Company nor its advisers have verified the accuracy or completeness of the information, or anystatements and opinion contained in this Presentation.

NOT INVESTMENT ADVICE

Each recipient of this Presentation should make its own enquiries and investigations regarding all information inthis Presentation including but not limited to the assumptions, uncertainties and contingencies which may affectfuture operations of Advanced Human Imaging and the impact that different future outcomes may have onAdvanced Human Imaging.

This Presentation has been prepared without taking account of any person's individual investment objectives,financial situation or particular needs. Before making an investment decision, prospective investors shouldconsider the appropriateness of the information having regard to their own investment objectives, financialsituation and needs and seek legal, accounting and taxation advice appropriate to their jurisdiction. AdvancedHuman Imaging is not licensed to provide financial product advice in respect of Advanced Human Imaging shares.

Cooling off rights do not apply to the acquisition of Advanced Human Imaging shares.

INVESTMENT RISK

An investment in Advanced Human Imaging shares is subject to known and unknown risks, some of which arebeyond the control of Advanced Human Imaging. Advanced Human Imaging does not guarantee any particularrate of return or the performance of Advanced Human Imaging nor does it guarantee any particular taxtreatment. An investment in Advanced Human Imaging should be considered as Highly Speculative and HighRisk due to the start up nature of the Company and its proposed business.

FINANCIAL DATA

All dollar values in this Presentation are in Australian dollars (A$ or AUD) unless otherwise stated.

FORWARD-LOOKING STATEMENTS

This Presentation may contain forward looking statements. The Australian words 'anticipate', 'believe','expect', 'project', 'forecast', 'estimate', 'likely', 'intend', 'should', 'could', 'may', 'target', 'plan' and othersimilar expressions are intended to identify forward-looking statements. Indications of, and guidanceon, future earnings and financial position and performance are also forward-looking statements.Forward-looking statements are subject to risk factors associated with the Company’s business, manyof which are beyond the control of the Company. It is believed that the expectations reflected inthese statements are reasonable but they may be affected by a variety of variables and changes inunderlying assumptions which could cause actual results or trends to differ materially from thoseexpressed or implied in such statements. There can be no assurance that actual outcomes will notdiffer materially from these statements. You should not place undue reliance on forward- lookingstatements and neither Advanced Human Imaging nor any of its directors, employees, advisers oragents assume any obligation to update such information.

DISCLAIMER

None of Advanced Human Imaging’s respective advisers or any of their respective affiliates, related bodiescorporate, directors, officers, partners, employees and agents, have authorized, permitted or caused the issue,submission, dispatch or provision of this Presentation and, except to the extent referred to in this Presentation,none of them makes or purports to make any statement in this Presentation and there is no statement in thisPresentation which is based on any statement by any of them.

To the maximum extent permitted by law, Advanced Human Imaging and its respective advisers,affiliates, related bodies corporate, directors, officers, partners, employees and agents exclude anddisclaim all liability, including without limitation for negligence or for any expenses, losses, damages orcosts incurred by you as a result of your participation in an investment in Advanced Human Imagingand the information in this Presentation being inaccurate or incomplete in any way for any reason,whether by negligence or otherwise.

To the maximum extent permitted by law, Advanced Human Imaging and its respective advisers,affiliates, related bodies corporate, directors, officers, partners, employees and agents make norepresentation or warranty, express or implied, as to the currency, accuracy, reliability or completenessof information in this Presentation.

Statements made in this Presentation are made only as the date of this Presentation. Theinformation in this Presentation remains subject to change without notice.

Disclaimer.

25

Vlado Bosanac

CEO, [email protected]

David Tabb

Chief Operations [email protected]

Bill Bradford

Chief Business Officer, USAbill.bradford@advancedhumanimaging.comwww.advancedhumanimaging.com

ASX: AHI

AdvancedHumanImaging.

Follow Us